NEWBORN SCREENING OF INFANTS AND NEWBORNS WITH CONGENITAL HYPOTHYROIDISM
Associate Professor Michelle Jack
Clinical Practice & Co-Lead Doctor of Medicine
Bond University, Queensland, Australia
RESEARCHER PROFILE
Filmed in Robina, Queensland | July 2024
Michelle Jack is Associate Professor of Clinical Practice, Faculty of Health Sciences & Medicine at Bond University, QLD and co-Head of Paediatrics and a Paediatric Endocrinologist at Lismore Base Hospital in NSW. She graduated from Medicine at the University of Queensland with first class honours and the University Gold Medal and has a PhD in hyperinsulinism from the University of QLD. She has postgraduate qualifications in higher education and is a fellow of the higher education academy.
Assoc Prof Jack is an experienced leader and practitioner in the healthcare, research and higher education sectors. Career highlights include: Head of Department Paediatric Endocrinology, Royal North Shore Hospital; Academic Lead Education & Partnerships, University Centre for Rural Health, University of Sydney; Head of the Beta Cell Laboratory, Kolling Institute; Chair Australasian Paediatric Endocrine Group scientific program organising committee and Co-Chair international scientific program organising committees; Chair Northern Sydney Adolescent Committee; International Research Fellowship, Juvenile Diabetes Research Foundation, Head of Research, Impact Institute.
Assoc Prof Jack is passionate about the health and wellbeing of children and adolescents, with diverse research areas including the impacts of family friendly workplace initiatives, screening and management of thyroid disorders in infants and children. She supports her First Nations colleagues on Indigenous-led research projects funded by the Medical Research Future Fund, aiming to improve the social and emotional wellbeing of First Nations Children. Through her clinical and academic roles, Assoc Prof Jack hopes to make a positive difference to the health and well-being of children and their families.
You Might also like
-
Environmental exposure to function of lung epithelial stem cell biology
Dr Clare Weeden has recently commenced as a Laboratory Head at WEHI in 2025, supported by the CSL Centenary Fellowship.
Dr Weeden specialises in lung epithelial cell biology in the context of homeostasis, inflammation, and lung cancer, particularly in people who don’t smoke. Her work endeavours to understand how past environmental exposures shape the responses of lung cells and the molecular mechanisms underlying this cellular recall, with the aim to develop novel early detection strategies for lung disease.
-
Identification, characterisation and role of leader cells in ovarian cancer progression
Dr. Maree Bilandzic is a molecular cancer biologist dedicated to advancing the understanding and treatment of ovarian cancer (OC). Her research addresses critical gaps in OC treatment by investigating the mechanisms behind metastasis, chemotherapy resistance, and tumour recurrence. By utilising innovative methodologies and disease-representative models, Dr. Bilandzic has pioneered the identification and characterisation of leader cells (LCs)—a unique, stem-like subpopulation within tumours that plays a crucial role in OC progression.
-
Dr Meghan McIlwain
DR MEGHAN MCILWAIN, CLINICAL RESEARCH MANAGER
PRESIDENT, THE NEW ZEALAND ASSOCIATION OF CLINICAL RESEARCH,
AUCKLAND, NEW ZEALAND